Kedem Pharmaceuticals (GHLV) 10-K 2012 FY Annual report

Exhibit 32.2

Certification of Principal Financial Officer and Principal Accounting Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the annual report of Kedem Pharmaceuticals Inc. (the “Company”) on Form 10-K for the fiscal year ended May 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Audrey Lew, certify pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:  August 28, 2012
By:	/s/ Audrey Lew
	Audrey Lew
	Chief Financial Officer
	(Principal Financial Officer and Principal Accounting Officer)